(Q38978245)

English

DOT1L inhibitor EPZ-5676 displays synergistic antiproliferative activity in combination with standard of care drugs and hypomethylating agents in MLL-rearranged leukemia cells

scientific article

Statements

DOT1L inhibitor EPZ-5676 displays synergistic antiproliferative activity in combination with standard of care drugs and hypomethylating agents in MLL-rearranged leukemia cells (English)
Christine R Klaus
Dorothy Iwanowicz
Danielle Johnston
Carly A Campbell
Robert A Copeland
Margaret Porter Scott
Alejandra Raimondi

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit